drugset / Trial / NCT01092546
Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
NaSingle-groupOpen-labelDiagnostic
Summary
To determine the level of association between the quantitative estimates of brain uptake of \[18F\]flutemetamol and the quantitative immunohistochemical and histochemistry estimates of amyloid levels in frontal lobe biopsy samples obtained from subjects during shunt placement for NPH.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flutemetamol | Diagnostic / imaging agent | 10 mg | Intravenous |
| Subject | Flutemetamol | Diagnostic / imaging agent | 185 mbq | Intravenous |